Adaptam Therapeutics vs CSF Biosciences
Adaptam Therapeutics vs CSF Biosciences, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptam Therapeutics is on 53/100 and CSF Biosciences on 48/100.
Where each one leads
Adaptam Therapeutics
- our overall score: 53/100 against 48/100
CSF Biosciences
- funding raised: $15.0M against $4.7M
At a glance
| Measure | Adaptam Therapeutics | CSF Biosciences |
|---|---|---|
| What it is | Developing novel therapeutics for rare genetic diseases with a focus on protein degradation. | Develops novel protein engineering and directed evolution technologies for therapeutic discovery. |
| Category | Biotech, Drug Discovery, Genomics, Rare Diseases | Biotech, Drug Discovery, Protein Engineering, Directed Evolution |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2021 | 2022 |
| Headquarters | Cambridge, United States | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Adaptam Therapeutics | CSF Biosciences |
|---|---|---|
| Employees | 6 | Not published |
| Total funding | $4.7M | $15.0M |
| Latest round | Seed | Series A |
| LinkedIn followers | 604 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptam Therapeutics | CSF Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 48/100 |
| Traction | 33/100 | 36/100 |
| Team | Not published | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 5/100 | 5/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | Not published |
| Domain ratingLink authority, 0-100 | 4/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptam Therapeutics | CSF Biosciences |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
Adaptam Therapeutics vs CSF Biosciences: common questions
Which is better, Adaptam Therapeutics or CSF Biosciences?
On our 0-100 score Adaptam Therapeutics rates higher (53/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Adaptam Therapeutics and CSF Biosciences compare on the numbers?
Adaptam Therapeutics leads on our overall score (53/100 against 48/100). CSF Biosciences leads on funding raised ($15.0M against $4.7M).
Read the full Adaptam Therapeutics review and pricing or the CSF Biosciences review and pricing. You can also browse other Adaptam Therapeutics alternatives we track.